L O A D I N G...

Skip to content
  • #50000 (no title)
  • #50026 (no title)
  • Audio Playlist
  • CCPA
  • ChatBot
  • Contact
  • DMCA
  • Home
  • NewsBot
  • Privacy Policy
  • Temp page
  • Terms of Use
  • Ticker
  • Upcoming Earnings
  • Upcoming Economic Events

Market News Data

Category: Markets

QIAGEN announces plans to return approximately $300 million

From GlobeNewswire: QIAGEN N.V. is returning up to approximately $300 million to shareholders through a synthetic share repurchase combining direct

January 7, 2024

Guru Fundamental Report for ORCL

From “Nasdaq, Inc.”: ORACLE CORP (ORCL) has received the highest rating from Validea’s Multi-Factor Investor model based on the strategy

January 7, 2024

QIAGEN gibt Pläne zur Rückzahlung von rund $300 Mio. an

From GlobeNewswire: QIAGEN N.V. plans to offer a capital repayment through a synthetic share buyback, potentially up to $300 million,

January 7, 2024

Should You Buy Polkadot (DOT) While It’s Below $10?

From Nasdaq, Inc.: The Polkadot (CRYPTO: DOT) cryptocurrency saw a short-lived spike to nearly $10 per token on Christmas Day

January 7, 2024

Saudis cut crude prices to all regions amid oil-price weakness

From Dow Jones & Company: Saudi Aramco announces it’s cutting crude oil prices for all regions, including Asia, in response

January 7, 2024

Exagen Inc. Announces Select Preliminary Full-Year 2023

From GlobeNewswire: Exagen Inc. announces preliminary unaudited financial results for 2023, including a record volume of AVISE® CTD testing units

January 7, 2024

3 Reasons to Buy Toast Stock Like There’s No Tomorrow

From Nasdaq: The stock price of Toast (NYSE: TOST) has declined over 50% since its IPO in September 2021, significantly

January 7, 2024

Why stock-market investors will remain at mercy of shifting rate-cut expectations

From Dow Jones & Company: Stock investors are off to a rocky start in 2024, as expectations around Federal Reserve

January 7, 2024

Strong Q4 sales lift full year

From GlobeNewswire: Preliminary and unaudited results for 2023 show a double-digit organic growth of +12% in Q4. Key markets in

January 7, 2024

Is Symbotic Stock a Buy?

From Nasdaq, Inc.: Symbotic stock (NASDAQ: SYM) had exceptional growth last year, outperforming Nvidia. The company uses proprietary automation systems

January 7, 2024

Caribou Biosciences Appoints Tim Kelly as Chief Technology

From GlobeNewswire: Tim Kelly has been appointed as the chief technology officer at Caribou Biosciences, Inc. He brings over 25

January 7, 2024

Brokerage Firms Are Pitching Separately Managed Accounts. Here’s What to Know.

From Wall Street Journal: Investors are being drawn to personalized portfolios for their tax benefits and potential for high returns.

January 7, 2024

Why Photronics Rocketed 48.5% Higher in December

From Nasdaq: Photronics’ stock, NASDAQ: PLAB, surged 48.5% in December after the company reported impressive fourth fiscal quarter earnings. The

January 7, 2024

Gentex Announces eSight Acquisition Set to Showcase

From GlobeNewswire: Gentex Corporation (NASDAQ: GNTX) has just announced they have acquired eSight, a leading provider of vision enhancement technologies.

January 7, 2024

Disney Stock 2025 Forecast: Can a ‘Golden Cross’ Carry DIS Higher?

From Barchart: Despite underperforming the markets in the last decade, the 2025 forecast for Disney stock (DIS) is positive. Investors

January 7, 2024

The Best Stock Funds of 2023

From Dow Jones & Company: Despite losses in 2022, mutual-fund managers saw a rebound in large and megacap stocks, especially

January 7, 2024

3 Boneheaded Investing Mistakes I Pledge Not to Make (Again) in 2024 and Beyond

From Nasdaq, Inc.: The article discusses the importance of reflecting on past investing mistakes and learning from them to avoid

January 7, 2024

I have a house with a mortgage rate of 1.9%, but I’m moving over 2,000 miles away. Should I rent or sell?

From Dow Jones & Company: Tom and his family are looking to relocate from Seattle and are considering renting out

January 7, 2024

Akoya Biosciences and Thermo Fisher Scientific Announce a

From GlobeNewswire: Akoya Biosciences has announced a new license and distribution agreement with Thermo Fisher Scientific. The goal of the

January 7, 2024

James Gorman Just Wrapped Up a Successful Tenure at Morgan Stanley. It Almost Didn’t Turn Out That Way.

From Wall Street Journal: In June 2012, Morgan Stanley’s CEO James Gorman ordered a dry vodka martini at a St.

January 7, 2024

Microsoft’s Windows Faces a New Threat From an Old Enemy

From Nasdaq, Inc.: Microsoft’s Windows operating system remains dominant in the desktop market, with a 72% share at the end

January 7, 2024

Are You Missing Out on This Energy Stock’s Monster Dividend Raise?

From “Nasdaq”: Diamondback Energy (NASDAQ: FANG) has a high-octane dividend, with a rapidly rising base dividend. It gave investors a

January 7, 2024

J.M. Smucker Is Known for Consumer Foods Such as Jellies and Ice Cream Toppings. But 71% of Its Profits Come From Different Product Categories Entirely.

From Nasdaq: The J.M. Smucker company started out in 1897, selling apple butter before growing into the consumer-foods powerhouse it

January 7, 2024

3 Reasons to Choose a Roth 401(k) for Your Retirement Savings in 2024

From Nasdaq, Inc.: The beginning of the new year is the perfect time to plan your financial future. It’s beneficial

January 7, 2024

Financial Tips For Seniors To Thrive On A Budget In 2024

From Due Payments: In 2024, seniors will receive a 3.2% hike in Social Security payments, but the cost of living

January 7, 2024

Posts pagination

Previous 1 … 515 516 517 … 559 Next
All Right Reserved © MarketNewsData.com.
  • Investing
  • Business
  • Markets
  • Finance
  • Earnings
  • Crypto
  • Audio Playlist
  • All Upcoming Earnings
  • All Upcoming Events
  • CCPA
  • Terms of Use
  • DMCA
  • Privacy Policy
  • Contact Us